A detailed history of Edgestream Partners, L.P. transactions in Organon & Co. stock. As of the latest transaction made, Edgestream Partners, L.P. holds 75,256 shares of OGN stock, worth $566,677. This represents 0.02% of its overall portfolio holdings.

Number of Shares
75,256
Previous 10,429 621.6%
Holding current value
$566,677
Previous $100,000 703.0%
% of portfolio
0.02%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 12, 2025

BUY
$8.4 - $10.85 $544,546 - $703,372
64,827 Added 621.6%
75,256 $803,000
Q2 2025

Aug 13, 2025

BUY
$8.04 - $14.72 $83,849 - $153,514
10,429 New
10,429 $100,000
Q3 2024

Nov 14, 2024

BUY
$18.65 - $23.03 $3.84 Million - $4.74 Million
205,683 New
205,683 $3.93 Million

Others Institutions Holding OGN

About Organon & Co.


  • Ticker OGN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 254,330,000
  • Market Cap $1.92B
  • Description
  • Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...
More about OGN
Track This Portfolio

Track Edgestream Partners, L.P. Portfolio

Follow Edgestream Partners, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Edgestream Partners, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Edgestream Partners, L.P. with notifications on news.